Legend Biotech Corporation

Rachunek Zysków i Strat





Przychody TTM (mln): 520
EBIT TTM (mln): -323
index 0 1 2 3 4 5 6 7
Rok finansowy 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 24 49 57 76 90 117 285 627
Przychód Δ r/r 0.0% 108.2% 16.5% 32.2% 18.7% 30.3% 143.7% 120.0%
Marża brutto 100.4% 100.0% 100.0% -206.8% -249.0% 44.1% 42.3% 62.6%
EBIT (mln) 14 -2 -131 -313 -393 -456 -442 0
EBIT Δ r/r 0.0% -111.1% 8431.4% 139.4% 25.4% 16.0% -3.0% -100.0%
EBIT (%) 58.4% -3.1% -228.5% -414.1% -437.7% -389.6% -155.1% 0.0%
Koszty finansowe (mln) 0 0 0 4 1 11 22 22
EBITDA (mln) 14 -7 -126 -303 -379 -437 -422 -113
EBITDA(%) 59.3% -14.6% -219.4% -400.9% -422.2% -373.9% -147.9% -18.0%
Podatek (mln) 4 1 3 -4 0 1 -2 19
Zysk Netto (mln) 9 -3 -133 -303 -386 -446 -518 -177
Zysk netto Δ r/r 0.0% -129.7% 4676.3% 128.2% 27.3% 15.6% 16.1% -65.8%
Zysk netto (%) 39.7% -5.7% -232.2% -401.0% -430.1% -381.5% -181.8% -28.2%
EPS 0.0709 -0.0278 -1.01 -2.57 -2.74 -2.81 -2.94 -0.97
EPS (rozwodnione) 0.0709 -0.0278 -1.01 -2.57 -2.74 -2.81 -2.94 -0.97
Ilośc akcji (mln) 132 100 132 118 141 159 176 183
Ważona ilośc akcji (mln) 132 100 132 118 141 159 176 183
Waluta USD USD USD USD USD USD USD USD